1. Home
  2. LUCD
  3. LUCD News

Latest Lucid Diagnostics Inc. (LUCD) News on January 30, 2025

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume
LUCD

PR Newswire

17 days ago

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Inks New Partnership With VITALExam: Stock to Gain?
LUCD

Zacks

a month ago

Lucid Inks New Partnership With VITALExam: Stock to Gain?

LUCD

MT Newswires

a month ago

Lucid Diagnostics Secures 180-Day Extension to Regain Compliance With Nasdaq Listing Rules

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
LUCD

PR Newswire

a month ago

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters
LUCD

PR Newswire

a month ago

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
LUCD

PR Newswire

2 months ago

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones
LUCD

PR Newswire

2 months ago

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
LUCD

PR Newswire

2 months ago

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
LUCD

PR Newswire

2 months ago

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

LUCD

Thomson Reuters StreetEvents

2 months ago

Q3 2024 PAVmed Inc Earnings Call

PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring
LUCD

GuruFocus.com

2 months ago

PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring

PAVmed Provides Business Update and Third Quarter 2024 Financial Results
LUCD

PR Newswire

3 months ago

PAVmed Provides Business Update and Third Quarter 2024 Financial Results

LUCD

GuruFocus.com

3 months ago

Lucid Diagnostics Inc (LUCD) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amid ...

Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
LUCD

PR Newswire

3 months ago

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
LUCD

PR Newswire

3 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024
LUCD

PR Newswire

3 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test
LUCD

PR Newswire

4 months ago

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test

Castle Biosciences price target raised to $40 from $35 at BTIG
LUCD

TipRanks

4 months ago

Castle Biosciences price target raised to $40 from $35 at BTIG

Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit
LUCD

PR Newswire

4 months ago

Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit

Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024
LUCD

PR Newswire

4 months ago

Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024

Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players
LUCD

PR Newswire

4 months ago

Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players

American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test
LUCD

PR Newswire

4 months ago

American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements
LUCD

PR Newswire

4 months ago

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress
LUCD

PR Newswire

5 months ago

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health
LUCD

PR Newswire

5 months ago

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer
LUCD

PR Newswire

5 months ago

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer

LUCD

Thomson Reuters StreetEvents

6 months ago

Q2 2024 PAVmed Inc Earnings Call

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer
LUCD

PR Newswire

6 months ago

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer

PAVmed Provides Business Update and Second Quarter 2024 Financial Results
LUCD

PR Newswire

6 months ago

PAVmed Provides Business Update and Second Quarter 2024 Financial Results

LUCD

MT Newswires

6 months ago

Lucid Diagnostics Shares Rise Following Q2 Results

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results
LUCD

PR Newswire

6 months ago

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event
LUCD

PR Newswire

6 months ago

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing
LUCD

PR Newswire

6 months ago

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing

Lucid Diagnostics to Participate in Upcoming Investor Conferences
LUCD

PR Newswire

6 months ago

Lucid Diagnostics to Participate in Upcoming Investor Conferences

PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024
LUCD

PR Newswire

6 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024
LUCD

PR Newswire

6 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume
LUCD

PR Newswire

6 months ago

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Launches New Corporate Website
LUCD

PR Newswire

7 months ago

Lucid Diagnostics Launches New Corporate Website

Lucid Diagnostics (LUCD) Reports Positive ESOGUARD BE-1 Data
LUCD

Zacks

7 months ago

Lucid Diagnostics (LUCD) Reports Positive ESOGUARD BE-1 Data

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
LUCD

PR Newswire

7 months ago

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing
LUCD

PR Newswire

8 months ago

4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing

LUCD

Thomson Reuters StreetEvents

9 months ago

Q1 2024 PAVmed Inc Earnings Call

LUCD

GuruFocus.com

9 months ago

Lucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...

PAVmed Provides Business Update and First Quarter 2024 Financial Results
LUCD

PR Newswire

9 months ago

PAVmed Provides Business Update and First Quarter 2024 Financial Results

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
LUCD

PR Newswire

9 months ago

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
LUCD

PR Newswire

9 months ago

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors
LUCD

PR Newswire

9 months ago

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024
LUCD

PR Newswire

9 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing
LUCD

PR Newswire

9 months ago

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month
LUCD

PR Newswire

9 months ago

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
LUCD

PR Newswire

10 months ago

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
LUCD

Insider Monkey

10 months ago

PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript

LUCD

Thomson Reuters StreetEvents

10 months ago

Q4 2023 PAVmed Inc Earnings Call

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript
LUCD

Insider Monkey

10 months ago

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript

LUCD

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Lucid Diagnostics Inc Earnings Call

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
LUCD

PR Newswire

10 months ago

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
LUCD

PR Newswire

10 months ago

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
LUCD

PR Newswire

10 months ago

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
LUCD

PR Newswire

10 months ago

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024
LUCD

PR Newswire

a year ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024

Lucid Diagnostics Provides Update Regarding World Trade Center Health Program
LUCD

PR Newswire

a year ago

Lucid Diagnostics Provides Update Regarding World Trade Center Health Program

Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony
LUCD

PR Newswire

a year ago

Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony

Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors
LUCD

PR Newswire

a year ago

Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors

Dow Jones Holds 38,000 Level Despite Intel Carnage; American Express Surges On Q4 Results
LUCD

Investor's Business Daily

a year ago

Dow Jones Holds 38,000 Level Despite Intel Carnage; American Express Surges On Q4 Results

PodcastOne Renews Agreement with The Adam Carolla Podcast and The Adam and Dr. Drew Show
LUCD

GlobeNewswire

a year ago

PodcastOne Renews Agreement with The Adam Carolla Podcast and The Adam and Dr. Drew Show

LUCD

Associated Press Finance

a year ago

Orrstown: Q4 Earnings Snapshot

Orrstown Financial Services, Inc. Reports Fourth Quarter 2023 Results and Record Earnings for Full Year 2023
LUCD

GlobeNewswire

a year ago

Orrstown Financial Services, Inc. Reports Fourth Quarter 2023 Results and Record Earnings for Full Year 2023

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck
LUCD

PR Newswire

a year ago

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck

Ampliphae, HPE Athonet and Arqit deliver Quantum-Safe Private 5G using Symmetric Key Agreement
LUCD

GlobeNewswire

a year ago

Ampliphae, HPE Athonet and Arqit deliver Quantum-Safe Private 5G using Symmetric Key Agreement

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred units
LUCD

GlobeNewswire

a year ago

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred units

All You Need to Know About 4D Molecular Therapeutics, Inc. (FDMT) Rating Upgrade to Strong Buy
LUCD

Zacks

a year ago

All You Need to Know About 4D Molecular Therapeutics, Inc. (FDMT) Rating Upgrade to Strong Buy

PRINCETON BANCORP, INC. AGREES TO ACQUIRE CORNERSTONE FINANCIAL CORPORATION
LUCD

PR Newswire

a year ago

PRINCETON BANCORP, INC. AGREES TO ACQUIRE CORNERSTONE FINANCIAL CORPORATION

New research warns of emerging "AI Gap" between brands and consumers
LUCD

PR Newswire

a year ago

New research warns of emerging "AI Gap" between brands and consumers

D-Wave to Participate in 26th Annual Needham Growth Conference
LUCD

Business Wire

a year ago

D-Wave to Participate in 26th Annual Needham Growth Conference

Surf Air Mobility and Williamsport, Pennsylvania Enter Agreement for Subsidized Commuter Air Service Between Williamsport Regional Airport (IPT) and Washington Dulles International Airport (IAD)
LUCD

Business Wire

a year ago

Surf Air Mobility and Williamsport, Pennsylvania Enter Agreement for Subsidized Commuter Air Service Between Williamsport Regional Airport (IPT) and Washington Dulles International Airport (IAD)

Maiden Holdings Ltd Director Yehuda Neuberger Sells 277,000 Shares
LUCD

GuruFocus.com

a year ago

Maiden Holdings Ltd Director Yehuda Neuberger Sells 277,000 Shares

INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
LUCD

GlobeNewswire

a year ago

INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer

LUCD

Business Wire

a year ago

Focus Impact BH3 Acquisition Announces LOI With XCF Global Capital

LUCD

GlobeNewswire

a year ago

Zoomcar, the World’s Largest Emerging Market Focused Car Sharing Platform, Announces Completion of its Business Combination with Innovative International Acquisition Corporation (IOAC) and Anticipated Nasdaq Listing

While institutions own 21% of Perfect Corp. (NYSE:PERF), public companies are its largest shareholders with 41% ownership
LUCD

Simply Wall St.

a year ago

While institutions own 21% of Perfect Corp. (NYSE:PERF), public companies are its largest shareholders with 41% ownership

CMCT Declares Common Stock Dividend
LUCD

Business Wire

a year ago

CMCT Declares Common Stock Dividend

Returns On Capital Are Showing Encouraging Signs At Aris Water Solutions (NYSE:ARIS)
LUCD

Simply Wall St.

a year ago

Returns On Capital Are Showing Encouraging Signs At Aris Water Solutions (NYSE:ARIS)

The 3 Most Undervalued Penny Stocks to Buy in December
LUCD

InvestorPlace

a year ago

The 3 Most Undervalued Penny Stocks to Buy in December

Insider Sell Alert: President and CEO HULL THOMAS DAVID III Sells 6,000 Shares of Kewaunee ...
LUCD

GuruFocus.com

a year ago

Insider Sell Alert: President and CEO HULL THOMAS DAVID III Sells 6,000 Shares of Kewaunee ...

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies
LUCD

PR Newswire

a year ago

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies

PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders
LUCD

PR Newswire

a year ago

PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders

Investors in Everspin Technologies (NASDAQ:MRAM) have seen decent returns of 65% over the past three years
LUCD

Simply Wall St.

a year ago

Investors in Everspin Technologies (NASDAQ:MRAM) have seen decent returns of 65% over the past three years

Tom Ferry, Hub International Join the RE/MAX® Marketplace, Bringing Fresh Content and Savings to Affiliates
LUCD

PR Newswire

a year ago

Tom Ferry, Hub International Join the RE/MAX® Marketplace, Bringing Fresh Content and Savings to Affiliates

Insider Buying: SuRo Capital Corp's Mark Klein Acquires 49,885 Shares
LUCD

GuruFocus.com

a year ago

Insider Buying: SuRo Capital Corp's Mark Klein Acquires 49,885 Shares

LUCD

Business Wire

a year ago

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

Powerfleet Named a Top Innovator by ABI Research
LUCD

PR Newswire

a year ago

Powerfleet Named a Top Innovator by ABI Research

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split
LUCD

PR Newswire

a year ago

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

Investors in Neuronetics (NASDAQ:STIM) from five years ago are still down 90%, even after 40% gain this past week
LUCD

Simply Wall St.

a year ago

Investors in Neuronetics (NASDAQ:STIM) from five years ago are still down 90%, even after 40% gain this past week

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium
LUCD

GlobeNewswire

a year ago

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

Fenix 360 Pte Ltd. To Go Public Through Merger With DUET Acquisition Corp. to Create a Global Social Media Platform
LUCD

GlobeNewswire

a year ago

Fenix 360 Pte Ltd. To Go Public Through Merger With DUET Acquisition Corp. to Create a Global Social Media Platform

Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference
LUCD

GlobeNewswire

a year ago

Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
LUCD

GlobeNewswire

a year ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript
LUCD

Insider Monkey

a year ago

PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript

Share on Social Networks: